Advanced Biomed Common Stock Performance
| ADVB Stock | 0.24 0.02 7.69% |
The firm shows a Beta (market volatility) of 1.5, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Advanced Biomed will likely underperform. At this point, Advanced Biomed Common has a negative expected return of -0.73%. Please make sure to confirm Advanced Biomed's potential upside and the relationship between the accumulation distribution and period momentum indicator , to decide if Advanced Biomed Common performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Advanced Biomed Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets - Stocktwits | 11/20/2025 |
2 | Inotiv Partners with VUGENE to Advance AI-Driven Drug Discovery and Bioinformatics Capabilities - Sahm | 12/11/2025 |
3 | Why retail investors favor Advanced Biomed Inc. stock - 2025 Bull vs Bear Daily Stock Momentum Reports - DonanmHaber | 12/18/2025 |
4 | Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary | 12/30/2025 |
5 | Advanced Biomed Signs Securities Purchase Agreement With Certain Investors - TradingView | 02/02/2026 |
| Begin Period Cash Flow | 80.4 K | |
| Total Cashflows From Investing Activities | -985.00 |
Advanced Biomed Relative Risk vs. Return Landscape
If you would invest 41.00 in Advanced Biomed Common on November 8, 2025 and sell it today you would lose (17.00) from holding Advanced Biomed Common or give up 41.46% of portfolio value over 90 days. Advanced Biomed Common is currently does not generate positive expected returns and assumes 5.5647% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Advanced, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Advanced Biomed Target Price Odds to finish over Current Price
The tendency of Advanced Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.24 | 90 days | 0.24 | close to 99 |
Based on a normal probability distribution, the odds of Advanced Biomed to move above the current price in 90 days from now is close to 99 (This Advanced Biomed Common probability density function shows the probability of Advanced Stock to fall within a particular range of prices over 90 days) .
Advanced Biomed Price Density |
| Price |
Predictive Modules for Advanced Biomed
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Advanced Biomed Common. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Advanced Biomed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Advanced Biomed Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Advanced Biomed is not an exception. The market had few large corrections towards the Advanced Biomed's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Advanced Biomed Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Advanced Biomed within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.96 | |
β | Beta against Dow Jones | 1.50 | |
σ | Overall volatility | 0.05 | |
Ir | Information ratio | -0.18 |
Advanced Biomed Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Advanced Biomed for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Advanced Biomed Common can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Advanced Biomed generated a negative expected return over the last 90 days | |
| Advanced Biomed has high historical volatility and very poor performance | |
| Advanced Biomed has some characteristics of a very speculative penny stock | |
| Advanced Biomed has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (101.52 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Advanced Biomed generates negative cash flow from operations | |
| Advanced Biomed has a frail financial position based on the latest SEC disclosures | |
| About 83.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors to Validate INBs Automated APOE Testing Platform for Alzheimers Disease |
Advanced Biomed Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Advanced Stock often depends not only on the future outlook of the current and potential Advanced Biomed's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Advanced Biomed's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.6 M | |
| Cash And Short Term Investments | 2.9 B |
Advanced Biomed Fundamentals Growth
Advanced Stock prices reflect investors' perceptions of the future prospects and financial health of Advanced Biomed, and Advanced Biomed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Advanced Stock performance.
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 3.52 M | ||||
| Shares Outstanding | 25.64 M | ||||
| Price To Book | 2.37 X | ||||
| EBITDA | (90.81 K) | ||||
| Net Income | (101.52 K) | ||||
| Total Debt | 1.26 M | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (181.46 K) | ||||
| Earnings Per Share | (0.16) X | ||||
| Market Capitalization | 6.78 M | ||||
| Total Asset | 6.51 B | ||||
| Retained Earnings | (19.23 B) | ||||
| Working Capital | 318.65 K | ||||
About Advanced Biomed Performance
By analyzing Advanced Biomed's fundamental ratios, stakeholders can gain valuable insights into Advanced Biomed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Advanced Biomed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Advanced Biomed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (165.53) | (173.81) |
Things to note about Advanced Biomed Common performance evaluation
Checking the ongoing alerts about Advanced Biomed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Advanced Biomed Common help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Advanced Biomed generated a negative expected return over the last 90 days | |
| Advanced Biomed has high historical volatility and very poor performance | |
| Advanced Biomed has some characteristics of a very speculative penny stock | |
| Advanced Biomed has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (101.52 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Advanced Biomed generates negative cash flow from operations | |
| Advanced Biomed has a frail financial position based on the latest SEC disclosures | |
| About 83.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors to Validate INBs Automated APOE Testing Platform for Alzheimers Disease |
- Analyzing Advanced Biomed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Advanced Biomed's stock is overvalued or undervalued compared to its peers.
- Examining Advanced Biomed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Advanced Biomed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Advanced Biomed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Advanced Biomed's stock. These opinions can provide insight into Advanced Biomed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Advanced Stock analysis
When running Advanced Biomed's price analysis, check to measure Advanced Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Biomed is operating at the current time. Most of Advanced Biomed's value examination focuses on studying past and present price action to predict the probability of Advanced Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Biomed's price. Additionally, you may evaluate how the addition of Advanced Biomed to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |